Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyp...

Por Engmann, L. L., Maslow, B. S., Kaye, L. A., Griffin, D. W., DiLuigi, A. J., Schmidt, D. W., Grow, D. R., Nulsen, J. C., Benadiva, C. A.
Publicado no J Ovarian Res (2019)